RxDoctor Payments Data

Eva Mutto

Psychiatric/Mental Health · North Chelmsford, MANPI 1306119854

Payments from drug & device makers

$2,277in general payments, 2019–2025

Across 106 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$457
  • Otsuka America Pharmaceutical, Inc.$232
  • Lundbeck LLC$207
  • Johnson & Johnson$132
  • Teva Pharmaceuticals USA, Inc.$58
  • plus $138 from 5 others

What the payments were for

  • Food & beverage$2,277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,277 in reported general payments places this provider in the 85th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$176,406
Medicare patients
192
Services billed
2,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl38$58,213
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine67$1,169
Quetiapine Fumarate19$801
Oxcarbazepine17$698
Clonazepam60$519
Gabapentin40$500
Alprazolam65$408
Hydroxyzine Hcl14$279
Olanzapine29$210
Venlafaxine Hcl ErVenlafaxine Hcl21$196
Duloxetine Hcl31$167
Divalproex Sodium11$155
Citalopram HbrCitalopram Hydrobromide12$145
Lorazepam35$144
Trazodone Hcl14$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,054$58,21338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

Other psychiatric/mental health in North Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →